• Phare
  • Validé par KD/KO

Anticorps Polyclonal de lapin anti-PAR2

PAR2 Polyclonal Antibody for WB, ELISA

Hôte / Isotype

Lapin / IgG

Réactivité testée

Humain et plus (1)

Applications

WB, ELISA

Conjugaison

Non conjugué

N° de cat : 12160-1-AP

Synonymes

F2RL1, G protein coupled receptor 11, GPR11, PAR 2, PAR2, Thrombin receptor like 1



Applications testées

Résultats positifs en WBcellules COLO 320,

Dilution recommandée

ApplicationDilution
Western Blot (WB)WB : 1:500-1:1000
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, check data in validation data gallery

Informations sur le produit

12160-1-AP cible PAR2 dans les applications de WB, ELISA et montre une réactivité avec des échantillons Humain

Réactivité Humain
Réactivité citéerat, Humain
Hôte / Isotype Lapin / IgG
Clonalité Polyclonal
Type Anticorps
Immunogène PAR2 Protéine recombinante Ag2801
Nom complet coagulation factor II (thrombin) receptor-like 1
Masse moléculaire calculée 397 aa, 44 kDa
Poids moléculaire observé 50-55 kDa
Numéro d’acquisition GenBankBC018130
Symbole du gène F2RL1
Identification du gène (NCBI) 2150
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Purification par affinité contre l'antigène
Tampon de stockage PBS avec azoture de sodium à 0,02 % et glycérol à 50 % pH 7,3
Conditions de stockageStocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA.

Informations générales

Proteinase-activated receptors (PARs) are G protein-coupled receptors activated through cleavage of their N-termini by mainly serine proteases. The family of PARs includes four members: PAR1, PAR2, PAR3, and PAR4. PAR2, also known as F2RL1, is expressed in epithelial cells (e.g., lung, gastrointestinal tract), endothelial cells, smooth muscle cells, fibroblasts, nerves, and some immune and inflammatory cells. PAR2 knockout mice and PAR2 agonists and antagonists have implicated PAR2 as a promising target in inflammatory conditions; respiratory, gastrointestinal, metabolic, cardiovascular, and neurological dysfunction; and cancers. (PMID:23895492)

Protocole

Product Specific Protocols
WB protocol for PAR2 antibody 12160-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols

Publications

SpeciesApplicationTitle

J Med Chem

Toward drugs for protease-activated receptor 2 (PAR2).

Authors - Mei-Kwan Yau
humanWB

Cells

Modulation of Intestinal Epithelial Permeability via Protease-Activated Receptor-2-Induced Autophagy.

Authors - Yuju Kim
humanWB

Biochem J

Protease-Activated Receptor-2 promotes kidney tubular epithelial inflammation by inhibiting autophagy via the PI3K/Akt/mTOR signalling pathway.

Authors - Chunyang Du
humanWB

Med Oncol

Long non-coding RNA AC245100.4 contributes to prostate cancer migration via regulating PAR2 and activating p38-MAPK pathway.

Authors - Chi Liu
  • KD Validated
humanWB

Heliyon

Long non-coding RNA AC245100.4 activates the PI3K/AKT pathway to promote PCa cell proliferation by elevating PAR2

Authors - Ke Zhang
human,ratWB

Mediators Inflamm

Protease-Activated Receptor-2 and Phospholipid Metabolism Analysis in Hyperuricemia-Induced Renal Injury

Authors - Xiaolu Sui
  • KD Validated